Trials / Withdrawn
WithdrawnNCT03973021
Very Small Embryonic-like Stem Cells for Erectile Dysfunction
Autologous Very Small Embryonic-like Stem Cells(VSELs) for Organic Erectile Dysfunction
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- Male
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to organic erectile dysfunction, such as those associated with metabolic syndrome or the treatment of prostate cancer.
Detailed description
By enrolling patients with organic erectile dysfunction adapted to enrolled criteria, this study will document for the first time the safety and efficacy of underlying penile cellular damage. The safety will be evaluated by tolerance degree. The efficacy will be evaluated validated scores and color duplex Doppler ultrasound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Very small embryonic-like stem cell(VSEL) | Mononuclear cells were collected from peripheral blood of each patient using a machine, VSELs were isolated, and each group was injected according to different numbers after activation |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-05-20
- Completion
- 2020-07-01
- First posted
- 2019-06-04
- Last updated
- 2020-10-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03973021. Inclusion in this directory is not an endorsement.